Peptide carrier fusion proteins as allergy vaccines
AssigneeBiomay AG
InventorsKatarzyna Niespodziana, Margarete Focke-Tejkl, Susanne Vrtala, Srinita Banerjee, Kuan-Wei Chen, Milena Weber, Rudolf Valenta, Katharina Marth
Life of this patent
Estimating the term…
Abstract
The present invention relates to a polypeptide comprising at least three peptide fragments consisting of 10 to 50 consecutive amino acid residues of at least one wild-type allergen fused to the N- and C-terminus of a surface polypeptide of a virus of the hepadnaviridae family or at least one fragment of said surface polypeptide.
Claims17
A polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID No. 14, SEQ ID No. 15, SEQ ID No. 16, SEQ ID No. 17, SEQ ID No. 18, SEQ ID No. 19, SEQ ID No. 20, SEQ ID No. 149, SEQ ID No. 150, SEQ ID No. 151 and SEQ ID No. 152.
Dependencies are inferred from the claim text.